Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Renal Cell 86Kidney Neoplasms 25Neoplasms 24Breast Neoplasms 18Gastrointestinal Stromal Tumors 17Neoplasm Metastasis 15Carcinoma, Non-Small-Cell Lung 15Prostatic Neoplasms 8Urinary Bladder Neoplasms 7Brain Neoplasms 7Pancreatic Neoplasms 6Lung Neoplasms 6Colorectal Neoplasms 6Thyroid Neoplasms 5Stomach Neoplasms 5Solid Tumors 5Small Cell Lung Carcinoma 5Ovarian Neoplasms 5Neuroendocrine Tumors 5Melanoma 5Glioblastoma 5Carcinoma 5Sarcoma 4Liver Neoplasms 4Esophageal Neoplasms 4Clear-cell metastatic renal cell carcinoma 4Carcinoma, Hepatocellular 4Astrocytoma 4Adenoma, Islet Cell 4Thyroid Cancer, Papillary 3

Interventions

padeliporfin 4motexafin gadolinium 2Sunitinib 2Radiotherapy 2Paclitaxel 2Genetic Testing 2Carboplatin 2vinflunine 1temsirolimus 1sipuleucel-T 1niraparib 1luprolide acetate gel depot 1apalutamide 1Tinzaparin 1Therapeutics 1Taste 1Surveys and Questionnaires 1Specimen Handling 1Sildenafil Citrate 1Remote Patient Monitoring 1Radiation Dose Hypofractionation 1Pemetrexed 1Ocoxin 1Neoadjuvant Therapy 1Leuprolide 1Immunotherapy 1Imatinib Mesylate 1Imagery, Psychotherapy 1Genetic Counseling 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Urogenital Neoplasms × Sunitinib × Clear all
NCT02060370 2020-02-27

Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)

M.D. Anderson Cancer Center

Phase 2 Completed
60 enrolled 13 charts
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Urogenital Neoplasms

NCT00460798 2010-11-16

SUNIKA

Pfizer

Completed
356 enrolled 8 charts
Genitourinary

Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡